cannabis
The Trump executive order moving cannabis to Schedule III could cut the FDA approval timeline from ten years to just twelve months - a reduction of 88 percent. By redefining marijuana’s federal status, the order aligns law with state medical programs and promises faster access to therapeutic products. Medical
cannabis
Yes, a tablespoon of hemp oil can cut post-workout muscle soreness by roughly half, offering a natural alternative to ibuprofen. In 2024, a double-blind trial with 120 cross-fit participants showed that daily hemp oil lowered inflammation markers more than placebo, sparking interest among recovery-focused athletes. Cannabis-Infused Hemp Oil Anti-Inflammatory Power
cannabis
Cannabis rescheduling to Schedule III increased deposit security for operators by roughly 80%, letting banks apply audit-ready safeguards previously limited to other high-risk sectors. The executive order signed by President Trump created a regulatory pathway that lets financial institutions treat cannabis deposits like any other high-risk commodity. Financial Disclaimer: This
cannabis
Federal cannabis rescheduling delivers the larger upside for operators because it removes the Schedule I stigma, opens mainstream banking, and expands the addressable market, whereas banking access alone only mitigates cash handling challenges. The pre-rescheduling banking restrictions cost operators an estimated $2.3 billion in missed revenue each year (Reuters)
cannabis
Sustainable hemp oil can power eco-friendly farms, and in 2023 closed-loop processing cut energy use by 25%. The oil is derived from industrial hemp, a fast-growing plant that sequesters carbon while producing a versatile biofuel. Farmers looking to lower emissions and diversify income are turning to this green alternative. Cannabis
cannabis
Hemp oil delivers strong economic benefits by offering a low-cost, high-nutrient cooking alternative and creating new revenue streams for farmers and processors. As more consumers seek plant-based oils, hemp oil’s market share is expanding beyond niche health circles. This shift is reshaping grocery aisles and farm income reports. Market
cannabis
Fortune Business Insights projects the global hemp seed oil market will reach $1.1 billion by 2034, and a single 30-ml bottle of hemp oil elixir costs around $30, making it far cheaper than the average college student’s $2-per-can energy drink habit. Financial Disclaimer: This article is for educational
cannabis operator cost savings
Federal rescheduling reduces operating expenses for cannabis businesses by allowing access to traditional banking and insurance services. The December 2025 executive order moved marijuana from Schedule I to a lower classification, unlocking financial tools previously barred. Operators now see lower transaction fees, broader credit options, and modest tax relief. Financial
cannabis
A recent seizure uncovered 240 pounds of cannabis hidden in the luggage of 22 Buddhist monks at Sri Lanka’s Bandaranaike International Airport. The find has ignited a nationwide conversation about drug policy, religious freedom, and potential economic opportunities tied to hemp. Authorities are now balancing strict anti-drug statutes with
cannabis
What Is Cannabis Oil In 2023, a systematic review identified 12 clinical trials evaluating THC-rich cannabis for chronic pain, indicating measurable pain reduction for many users. Cannabis oil is an extract made by infusing the plant’s cannabinoids - primarily THC and CBD - into a carrier oil such as
cannabis
Hoosiers are investing heavily in cannabis, with retail sales jumping 35% in 2023 and state taxes feeding $60 million into public services. The market’s growth reflects broader acceptance, tighter regulation, and a shift toward health-focused products. Below is a deep dive into the numbers, the legal backdrop, and what
cannabis
Direct answer: Cannabis does have health benefits, but the evidence is more nuanced than the headlines suggest. Media outlets and politicians often tout “miracle cures,” yet rigorous data tells a mixed story. I’ve spent the past decade consulting with patients, growers, and regulators, and the reality sits somewhere between